Pharmaceutical Nanotechnology
Volume 8, 6 Issues, 2020
ISSN: 2211-7393 (Online)
ISSN: 2211-7385 (Print)
This journal supports open access
Order Your Article Before Print
ISSN: 2211-7393 (Online)
ISSN: 2211-7385 (Print)
This journal supports open access
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research
Join Editorial Board
* These fields are mendatory.
Editor-in-Chief
Ijeoma F. Uchegbu
Department of Pharmaceutics
University of London
London
(UK)
Biography
View Full Editorial Board
Department of Pharmaceutics
University of London
London
Biography
Biography of Ijeoma F. Uchegbu
Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London (UCL), Pro-Vice Provost for Africa and The Middle East, UCL and Chief Scientific Officer of Nanomerics. She obtained her PhD from the School of Pharmacy, University of London in 1994. In 2015, Ijeoma became UCL’s Pro-Vice Provost for Africa and The Middle East. Nanomerics was founded in 2010 by Ijeoma and Andreas G. Schätzlein. Nanomerics is a specialtiy pharmaceutical company focused on exploiting pharmaceutical nanotechnology platforms for medicines development. Ijeoma has been awarded various prizes for her work, notably the UK Department for Business Innovation Skills’ Women of Outstanding Achievement in Science Engineering and Technology award and the Royal Pharmaceutical Society’s Pharmaceutical Scientist of the Year 2012. Ijeoma was elected to the Controlled Release Society College of Fellows in 2013 and became an Eminent Fellow of the Academy of Pharmaceutical Sciences in 2013.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Pharmaceutical Nanotechnology was launched in 2013. Dr. Ijeoma F. Uchegbu serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.42
Advertisement
Webmaster Contact: info@benthamscience.net